Esketamine Reduces Lung Injury Caused by Limb Ischemia-Reperfusion by Regulating Oxidative Stress via the TLR4/NF-κB/NLRP3 Pathway
Esketamine protected against LIR-induced ALI by mitigating oxidative stress and suppressing the TLR4/NF-κB/NLRP3 axis. These findings highlight the potential therapeutic value of esketamine for ALI.
Authors
- Meng Wang (ORCID: https://orcid.org/0000-0002-1202-3678)
- Wen‐Juan Wang (ORCID: https://orcid.org/0000-0003-4879-3188)
- Qian Ma (ORCID: https://orcid.org/0000-0002-3272-9723)
- Heng Wen (ORCID: https://orcid.org/0000-0001-8925-7643)
- Jiawei Cun
Institutions
- Ningxia Medical University (CN)
- First Affiliated Hospital Zhejiang University (CN)
Publication Details
- Journal
- Endocrine Metabolic & Immune Disorders - Drug Targets
- Published
- 2025-04-29
- DOI
- https://doi.org/10.2174/0118715303393744250423100211
- Citations
- 1
- Primary Topic
- Cardiac Ischemia and Reperfusion
- Type
- article
- Field-Weighted Citation Impact
- 1.47